Why Branding is Pharma’s Most Undervalued Asset
Apr 10, 01:00 PM
Share
Subscribe
In this episode of Leading Edge With Ken Banta, The Vanguard Network founder and CEO is joined by branding strategist Andy Milligan, founding partner of The Caffeine Partnership, where the duo examine why life sciences companies urgently need to rethink how they build, protect, and communicate their brands.
Highlights of the discussion include:
- Relevance + consistency = brand durability
- Trust is pharma’s defining — and fragile — currency
- The science-to-experience disconnect
- Storytelling as a strategic lever, especially in rare disease